AW
PACB icon

Avion Wealth’s Pacific Biosciences PACB Stock Holding History

Avion Wealth’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+435
New +$632 ﹤0.01% 1652
2025
Q2 		– Sell
-327
Closed – – 1487
2025
Q1 		$0 Buy
+327
New +$502 ﹤0.01% 1271

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Avion Wealth's PACB Position: Q2 2026 in Review

Avion Wealth opened a new position in Pacific Biosciences (PACB) in Q2 2026: 435 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1652 among its holdings. This is a return to the name: Avion Wealth previously reported a position in PACB as recently as Q1 2025.

Avion Wealth first reported a position in PACB in Q1 2025 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Avion Wealth held 435 shares of Pacific Biosciences worth $0 as of Q2 2026.
  • Pacific Biosciences was a new Avion Wealth position in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1652 holding.
  • Avion Wealth first reported a position in Pacific Biosciences in Q1 2025 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.